These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

898 related items for PubMed ID: 16207849

  • 1. Cost-effectiveness of implantable cardioverter-defibrillators.
    Sanders GD, Hlatky MA, Owens DK.
    N Engl J Med; 2005 Oct 06; 353(14):1471-80. PubMed ID: 16207849
    [Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.
    Chan PS, Stein K, Chow T, Fendrick M, Bigger JT, Vijan S.
    J Am Coll Cardiol; 2006 Jul 04; 48(1):112-21. PubMed ID: 16814657
    [Abstract] [Full Text] [Related]

  • 3. Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population.
    Cowie MR, Marshall D, Drummond M, Ferko N, Maschio M, Ekman M, de Roy L, Heidbuchel H, Verboven Y, Braunschweig F, Linde C, Boriani G.
    Europace; 2009 Jun 04; 11(6):716-26. PubMed ID: 19359333
    [Abstract] [Full Text] [Related]

  • 4. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator.
    Yao G, Freemantle N, Calvert MJ, Bryan S, Daubert JC, Cleland JG.
    Eur Heart J; 2007 Jan 04; 28(1):42-51. PubMed ID: 17110403
    [Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
    Mark DB, Nelson CL, Anstrom KJ, Al-Khatib SM, Tsiatis AA, Cowper PA, Clapp-Channing NE, Davidson-Ray L, Poole JE, Johnson G, Anderson J, Lee KL, Bardy GH, SCD-HeFT Investigators.
    Circulation; 2006 Jul 11; 114(2):135-42. PubMed ID: 16818817
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
    Zwanziger J, Hall WJ, Dick AW, Zhao H, Mushlin AI, Hahn RM, Wang H, Andrews ML, Mooney C, Wang H, Moss AJ.
    J Am Coll Cardiol; 2006 Jun 06; 47(11):2310-8. PubMed ID: 16750701
    [Abstract] [Full Text] [Related]

  • 8. Life expectancy gains and cost-effectiveness of implantable cardioverter/defibrillators for the primary prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    You JJ, Woo A, Ko DT, Cameron DA, Mihailovic A, Krahn M.
    Am Heart J; 2007 Nov 06; 154(5):899-907. PubMed ID: 17967596
    [Abstract] [Full Text] [Related]

  • 9. The cost-effectiveness of primary prophylactic implantable defibrillator therapy in patients with ischaemic or non-ischaemic heart disease: a European analysis.
    Smith T, Jordaens L, Theuns DA, van Dessel PF, Wilde AA, Hunink MG.
    Eur Heart J; 2013 Jan 06; 34(3):211-9. PubMed ID: 22584647
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Microvolt T-wave alternans and the selective use of implantable cardioverter defibrillators for primary prevention: a cost-effectiveness study.
    Filion KB, Xie X, van der Avoort CJ, Dendukuri N, Brophy JM.
    Int J Technol Assess Health Care; 2009 Apr 06; 25(2):151-60. PubMed ID: 19331707
    [Abstract] [Full Text] [Related]

  • 12. Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial.
    Feldman AM, de Lissovoy G, Bristow MR, Saxon LA, De Marco T, Kass DA, Boehmer J, Singh S, Whellan DJ, Carson P, Boscoe A, Baker TM, Gunderman MR.
    J Am Coll Cardiol; 2005 Dec 20; 46(12):2311-21. PubMed ID: 16360064
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in patients with left ventricular systolic dysfunction: 14 years after MADIT.
    Franqui-Rivera H, Sotomonte JC.
    P R Health Sci J; 2011 Jun 20; 30(2):78-83. PubMed ID: 21682151
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cost-effectiveness of the implantable cardioverter defibrillator.
    Hlatky MA, Sanders GD, Owens DK.
    Card Electrophysiol Rev; 2003 Dec 20; 7(4):479-82. PubMed ID: 15071279
    [Abstract] [Full Text] [Related]

  • 17. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II.
    Goldenberg I, Moss AJ, Hall WJ, McNitt S, Zareba W, Andrews ML, Cannom DS, Multicenter Automatic Defibrillator Implantation Trial (MADIT) II Investigators.
    Circulation; 2006 Jun 20; 113(24):2810-7. PubMed ID: 16769917
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.
    Buxton M, Caine N, Chase D, Connelly D, Grace A, Jackson C, Parkes J, Sharples L.
    Health Technol Assess; 2006 Aug 20; 10(27):iii-iv, ix-xi, 1-164. PubMed ID: 16904046
    [Abstract] [Full Text] [Related]

  • 20. Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death.
    Das M.
    Expert Rev Cardiovasc Ther; 2009 Feb 20; 7(2):181-95. PubMed ID: 19210214
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.